Patents by Inventor Sue-Jean Hong

Sue-Jean Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARS-COV-2 VACCINES
    Publication number: 20250121052
    Abstract: Disclosed herein are vaccine compositions that include SARS-CoV-2 MHC epitope-encoding cassettes and/or full-length SARS-CoV-2 proteins. Also disclosed are nucleotides, cells, and methods associated with the compositions including their use as vaccines.
    Type: Application
    Filed: May 8, 2024
    Publication date: April 17, 2025
    Inventors: Leonid Gitlin, Karin Jooss, Sue-Jean Hong, Ciaran Daniel Scallan, Amy Rachel Rappaport, Christine Denise Palmer, Minh Duc Cao
  • SELF-AMPLIFYING RNA COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20250108105
    Abstract: The present disclosure includes, among other things, RNA polynucleotide compositions that (A) include modified nucleosides; and/or (B) have been purified using a chromatography system and/or an affinity-based separation system. Methods of production and treatment related to the same are also provided.
    Type: Application
    Filed: May 8, 2024
    Publication date: April 3, 2025
    Inventors: Sue-Jean Hong, Mario Fidanza, Karin Jooss
  • PANCORONAVIRUS VACCINES
    Publication number: 20240238412
    Abstract: Disclosed herein are vaccine compositions that include Pancorona receptor binding domain (RBD) encoding cassettes and/or MHC epitope-encoding cassettes. Also disclosed are nucleotides, cells, and methods associated with the compositions including their use as vaccines.
    Type: Application
    Filed: March 29, 2024
    Publication date: July 18, 2024
    Inventors: Leonid Gitlin, Karin Jooss, Sue-Jean Hong, Ciaran Daniel Scallan, Amy Rachel Rappaport, Christine Denise Palmer, Minh Duc Cao, Joshua Klein
  • MODIFIED ALPHAVIRUS VECTORS
    Publication number: 20240167057
    Abstract: Disclosed herein are vaccine compositions that include alphavirus derived vectors having multiple expression cassettes driven by multiple subgenomic promoters.
    Type: Application
    Filed: July 18, 2023
    Publication date: May 23, 2024
    Inventor: Sue-Jean Hong
  • CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20230303614
    Abstract: The present disclosure includes, among other things, non-natural nucleotides useful as 5? caps for RNA nucleotides. The present disclosure also includes, among other things, compositions and methods using delivery and vaccine RNA nucleotide compositions that include non-natural nucleotides as 5? caps.
    Type: Application
    Filed: October 20, 2022
    Publication date: September 28, 2023
    Inventors: Karin Jooss, Amy Rachel Rappaport, Ciaran Daniel Scallan, Leonid Gitlin, Sue-Jean Hong, Arvin Akoopie